glp-1 pipeline Update: May 2026 - Prime Therapeutics GLP-1R: Therapeutic Target for Obesity
Description
Prefer listening
PlexusDx recommends tracking how you feelyour energy, mood, digestion, and hungerrather than obsessing over a calorie counter
Glucagon-like peptide-1 receptor agonist based medications (GLP-1s) have transformed the treatment landscape for type 2 diabetes and obesity over the past decade ( 1 , 2 )
No patients were involved in setting the research question or the outcome measures
S.GormanD
